Lundbeck
HLUN-B.CO
#2240
Rank
S$10.80 B
Marketcap
S$10.89
Share price
1.07%
Change (1 day)
16.36%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): S$0.48

According to Lundbeck's latest financial reports the company's current EPS (TTM) is S$0.97. In 2022 the company made an earnings per share (EPS) of S$0.34 a decrease over its 2021 EPS that were of S$0.77.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$0.4840.09%
2022S$0.34-55.47%
2021S$0.77-51.83%
2020S$1.61-28.01%
2019S$2.23-44.08%
2018S$3.9951.94%
2017S$2.62126.64%
2016S$1.16-120.84%
2015S-$5.565622.18%
2014S-$0.09712-110.03%
2013S$0.97-28.08%
2012S$1.35-52.1%
2011S$2.81-1.31%
2010S$2.8515.61%
2009S$2.46